Key insights
- Blackstone's May portfolio activity, including the sale of Recognition Music Group, Medallia restructuring, and investments in Skroutz and Anagram Therapeutics, signals active capital recycling across its diverse business segments. While recent stock performance has been mixed, these moves suggest a strategic shift in sector exposure and deal pacing, potentially influencing future cash flows and investor sentiment positively.
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.
In May 2026, Blackstone (NYSE:BX) announced the sale of Recognition Music Group to Sony Music and a lender-led restructuring of Medallia.
The firm also agreed to acquire a majority stake in Greek e-commerce platform Skroutz and arranged a financing package with Broadcom tied to AI chip development.
Additional moves included a large life sciences investment in Anagram Therapeutics and the launch of a real estate lending platform focused on affordable housing projects.
Blackstone is putting fresh attention on how its capital is allocated across private equity, credit, real estate, and life sciences. With the stock at $122.76, NYSE:BX has seen mixed performance, including gains of 6.9% over the past 30 days and 67.5% over 3 years, alongside declines of 22.7% year to date and 14.4% over the past year. These shifts provide important context as you think about how current moves sit against recent share price swings.
For investors watching NYSE:BX, this cluster of transactions offers new information beyond earlier headlines centered on valuation or AI partnerships. The activity touches several parts of Blackstone’s business model at once. This may help you assess how diversified cash flows, sector exposure, and deal pacing are evolving from here.
Stay updated on the most important news stories for Blackstone by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Blackstone.
2 things going right for Blackstone that this headline doesn't cover.
This cluster of May 2026 moves shows Blackstone actively recycling capital and leaning on multiple engines of its platform at once. The sale of Recognition Music Group to Sony Music converts an entertainment asset into cash that can be redirected, while the Medallia lender-led restructuring highlights how private credit exposure can shift from debt-holder to owner when stressed deals do not perform as planned. At the same time, the agreement to acquire a majority stake in Skroutz gives Blackstone more exposure to European e-commerce, and the Broadcom AI chip financing talks point to continued focus on large private credit transactions tied to AI infrastructure. The US$250 million commitment to Anagram Therapeutics and the new real estate lending platform for affordable housing show that life sciences and housing remain active areas for deployment. For you as an investor, the key question is how this blend of exits, restructurings, new equity stakes, and credit commitments influences fee related earnings potential and the balance of risk across Blackstone’s funds.
The Broadcom financing, Skroutz acquisition, and Anagram Therapeutics funding align with the existing narrative that Blackstone is using a large capital base to pursue deal flow across private credit, technology-driven businesses, and life sciences.
The Medallia debt-to-equity conversion illustrates how challenging exits and stressed leverage can weigh on realizations, which is one of the risks analysts already highlight when discussing deployment and earnings trajectories.
The affordable housing lending platform and rotation out of Recognition Music Group into new opportunities are not fully captured in earlier discussions that focused more on broad inflows, private credit spreads, and AI data-center exposure, so they add extra texture to the story you are weighing.
Knowing what a company is worth starts with understanding its story. Check out one of the top narratives in the Simply Wall St Community for Blackstone to help decide what it's worth to you.
⚠️ The Medallia restructuring shows how pandemic-era leveraged buyouts that struggle with heavy debt loads can erode equity value and introduce credit risk inside Blackstone’s portfolios.
⚠️ Large single transactions such as the proposed US$35b Broadcom financing could concentrate exposure if deal terms or AI chip demand do not line up with expectations across cycles.
🎁 The Skroutz majority stake, Anagram Therapeutics investment, and affordable-housing credit platform broaden Blackstone’s reach across e-commerce, life sciences, and residential real estate, which may support more diversified fee streams over time.
🎁 The AI-focused financing with Broadcom aligns Blackstone with a large capital need in AI chips, an area where peers like KKR and Apollo are also active, and may help the firm remain competitive in winning large private credit mandates.
From here, keep an eye on how Blackstone reports realizations from sales like Recognition Music Group, updates around the Medallia restructuring, and the timing and structure of the Broadcom financing package relative to moves by Apollo, KKR, or Carlyle. Watch for disclosures on fee related earnings and performance fees linked to Skroutz, Anagram Therapeutics, and the new housing lending platform, as these will show how quickly new deals start to contribute. It is also worth tracking any commentary on portfolio credit quality and leverage, particularly where stressed situations could mirror Medallia. To ensure you are always in the loop on how this type of activity shifts the risk and reward balance for NYSE:BX, monitoring these themes across future earnings calls and fund updates can be helpful.
To ensure you're always in the loop on how the latest news impacts the investment narrative for Blackstone, head to the community page for Blackstone to never miss an update on the top community narratives.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BX.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com